Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system

被引:20
作者
Labrador Barba, Elena [1 ]
Rodriguez de Miguel, Marta [1 ]
Hernandez-Mijares, Antonio [2 ,3 ]
Javier Alonso-Moreno, Francisco [4 ]
Luisa Orera Pena, Maria [1 ]
Aceituno, Susana [5 ]
Jose Faus Dader, Maria [6 ]
机构
[1] Mylan, Dept Med, Madrid, Spain
[2] Doctor Peset Univ Hosp, Dept Endocrinol & Nutr, Valencia, Spain
[3] Univ Valencia, Dept Med, Valencia, Spain
[4] Ctr Salud Silleria, Dept Primary Hlth Care, Toledo, Spain
[5] Outcomes 10, Castellon de La Plana, Spain
[6] Univ Granada, Dept Biochem & Mol Biol, Fac Pharm, Granada, Spain
来源
PATIENT PREFERENCE AND ADHERENCE | 2017年 / 11卷
关键词
type 2 diabetes mellitus; adherence; persistence; factors; strategies; HOSPITALIZATION; NONADHERENCE; PREVALENCE; MANAGEMENT; MORTALITY; BARRIERS; OUTCOMES; QUALITY; IMPACT;
D O I
10.2147/PPA.S122556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: A good relationship between diabetes patients and their health care team is crucial to ensure patients' medication adherence and self-management. To this end, we aimed to identify and compare the views of type 2 diabetes mellitus (T2DM) patients, physicians and pharmacists concerning the factors and strategies that may be associated with, or could improve, medication adherence and persistence. Methods: An observational, cross-sectional study was conducted using an electronic self-administered questionnaire comprising 11 questions (5-point Likert scale) concerning factors and strategies related to medication adherence. The survey was designed for T2DM patients and Spanish National Health System professionals. Results: A total of 963 T2DM patients, 998 physicians and 419 pharmacists participated in the study. Overall, a lower proportion of pharmacists considered the proposed factors associated with medication adherence important as compared to patients and physicians. It should be noted that a higher percentage of physicians in comparison to pharmacists perceived that "complexity of medication" (97% vs 76.6%, respectively) and "adverse events" (97.5% vs 72.2%, respectively) were important medication-related factors affecting adherence. In addition, both patients (80.8%) and physicians (80.8%) agreed on the importance of "cost and co-payment" for adherence, whereas only 48.6% of pharmacists considered this factor important. It is also noteworthy that nearly half of patients (43%) agreed that "to adjust medication to activities of daily living" was the best strategy to reduce therapeutic complexity, whereas physicians believed that "reducing the frequency of administration" (47.9%) followed by "reducing the number of tablets" (28.5%) was the most effective strategy to improve patients' adherence. Conclusion: Our results highlight the need for pharmacists to build a stronger relationship with physicians in order to improve patients monitoring and adherence rates. Additionally, these findings may help to incorporate greater patient-centeredness when developing management strategies, focusing on adjusting medication regimens to patients' daily lives.
引用
收藏
页码:707 / 718
页数:12
相关论文
共 50 条
  • [21] Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus
    Al Mazroui, Nadia Rashid
    Kamal, Mostafa Mohamed
    Ghabash, Naserdeen Mehana
    Yacout, Targ Ahmed
    Kole, Prashant Laxman
    McElnay, James C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (05) : 547 - 557
  • [22] Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
    O'Hara, Daniel, V
    Janse, Roemer J.
    Fu, Edouard L.
    Jardine, Meg J.
    Carrero, Juan-Jesus
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 213
  • [23] Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study
    Franch-Nadal, Josep
    Garcia-Gollarte, Fermin
    Perez del Molino, Alfonso
    Orera-Pena, Maria L.
    Rodriguez de Miguel, Marta
    Melogno-Klinkas, Malena
    de Paz, Hector D.
    Aceituno, Susana
    Rodriguez-Fortunez, Patricia
    CLINICAL DRUG INVESTIGATION, 2019, 39 (01) : 73 - 84
  • [24] Relationship Between Continuity of Ambulatory Care and Medication Adherence in Adult Patients With Type 2 Diabetes in Korea A Longitudinal Analysis
    Hong, Jae-Seok
    Kang, Hee-Chung
    MEDICAL CARE, 2014, 52 (05) : 446 - 453
  • [25] Factors related to barriers and medication adherence in patients with type 2 diabetes mellitus: a cross-sectional study
    Zairina, Elida
    Nugraheni, Gesnita
    Sulistyarini, Arie
    Mufarrihah
    Setiawan, Catur Dian
    Kripalani, Sunil
    Lestari, Safira Indah
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 219 - 228
  • [26] The impact of incident depression on medication adherence in patients with type 2 diabetes
    Lunghi, C.
    Zongo, A.
    Moisan, J.
    Gregoire, J. -P.
    Guenette, L.
    DIABETES & METABOLISM, 2017, 43 (06) : 521 - 528
  • [27] Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus
    Raum, Elke
    Kraemer, Heike U.
    Rueter, Gernot
    Rothenbacher, Dietrich
    Rosemann, Thomas
    Szecsenyi, Joachim
    Brenner, Hermann
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (03) : 377 - 384
  • [28] Evaluating Financial Incentives as a Tool to Increase Medication Adherence for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Winberg, Debra
    Tang, Tiange
    Ramsey, Zachary
    Bazzano, Alessandra N.
    Nauman, Elizabeth
    Li, Jian
    Lin, Yilu
    Shi, Lizheng
    DIABETES THERAPY, 2025, 16 (03) : 527 - 545
  • [29] Profiling of patients with type 2 diabetes based on medication adherence data
    Markovic, Rene
    Grubelnik, Vladimir
    Zavrsnik, Tadej
    Blazun Vosner, Helena
    Kokol, Peter
    Perc, Matjaz
    Marhl, Marko
    Zavrsnik, Matej
    Zavrsnik, Jernej
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [30] Medication non-adherence in patients with type 2 diabetes mellitus with full access to medicines
    Saraiva, Emanuela Machado Silva
    Coelho, Jose Leonardo Gomes
    dos Santos Figueiredo, Francisco Winter
    do Souto, Ricardo Peres
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (02) : 1105 - 1113